|本期目录/Table of Contents|

[1]刘利维,刘春雨. MicroRNAs 与前列腺癌的表观遗传学研究进展[J].天津医科大学学报,2014,20(01):74-076.
点击复制

  MicroRNAs 与前列腺癌的表观遗传学研究进展(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
20卷
期数:
2014年01期
页码:
74-076
栏目:
综述
出版日期:
2014-01-20

文章信息/Info

Title:
-
文章编号:
1006-8147(2014)01-0074-03
作者:
  刘利维; 刘春雨
（天津医科大学第二医院泌尿外科，天津 300211）
Author(s):
-
关键词:
前列腺癌; 表观遗传; 微小RNA
Keywords:
-
分类号:
R737.25
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

 [1]. Carter H B.American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale[J]. BJU Int, 2013 ,112(5):543

[2]. Punnen S, Cooperberg M R.The epidemiology of high-risk prostate cancer[J]. Curr Opin Urol, 2013,23(4):331

[3]. Sfoungaristos S, Perimenis P.PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancer[J]. Can Urol Assoc J, 2012 ,6(1):46

[4]. Madan R A, Arlen P M.Recent advances revolutionize treatment of metastatic prostate cancer[J]. Future Oncol, 2013,9(8):1133

[5]. Shaikhibrahim Z,Lindstrot A, Ochsenfahrt J, et al.Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines[J]. Int J Mol Med, 2013,31(1):21

[6]. Lin J, Wang C, Kelly W K. Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions[J]. Semin Oncol, 2013,40(3):393

[7]. Shu L, Khor T O, Lee J H, et al. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells[J]. AAPS J, 2011,13(4):606

[8]. Luo J H, Ding Y, Chen R, et al. Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer[J]. Am J Pathol, 2013,182(6):2028

[9]. Sandhu S, Garzon R. Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment[J].Semin Oncol, 2011,38(6):781

[10]. Raisch J, Darfeuille-Michaud A, Nguyen H T. Role of microRNAs in the immune system, inflammation and cancer[J]. World J Gastroenterol,2013,19(20):2985

[11]. Choo K B. Epigenetics in disease and cancer[J].Malays J Pathol,2011,33(2):61

[12]. Cao P, Deng Z, Wan M, et al.MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta[J].Mol Cancer, 2010,17:108

[13]. Varambally S, Cao Q, Mani R S, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 incancer[J].Science, 2008, 322(5908):1695

[14]. Noonan E J, Place R F, Pookot D, et al.miR-449a targets HDAC-1 and induces growth arrest in prostate cancer[J].Oncogene, 2009,28(14):1714

[15]. Hulf T, Sibbritt T, Wiklund E D,et al. Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription[J]. BMC Genomics, 2011,12:54

[16]. Kong D, Banerjee S, Ahmad A, et al.Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures inprostate cancer cells[J].PLoS One, 2010, 5(8):e12445

[17]. Musiyenko A, Bitko V, Barik S.Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells[J].J Mol Med (Berl), 2008,86(3):313

[18]. Avgeris M, Stravodimos K, Fragoulis E G, et al. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients[J]. Br J Cancer,2013,108(12):2573

[19]. Amankwah E K, Anegbe E, Park H, et al.miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases[J]. Asian J Androl, 2013,15(2):226

[20]. Mitsiades N.A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer[J]. Cancer Res,2013,73(15):4599

[21]. Waltering K K, Porkka K P, Jalava S E, et al. Androgen regulation of micro-RNAs in prostate cancer[J].Prostate, 2011,71(6):604

[22]. Kashat M, Azzouz L, Sarkar S H. Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness[J]. Am J Transl Res,2012,4(4):432

[23]. Östling P, Leivonen S K, Aakula A, et al. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancercells[J]. Cancer Res,2011,71(5):1956

[24]. Rokhlin O W, Scheinker V S, Taghiyev A F, et al. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer[J]. Cancer Biol Ther,2008,7(8):1288

[25]. Zhu K C, Lu J J, Xu X L, et al. MicroRNAs in androgen-dependent PCa[J]. Front Biosci,2013,18:748

相似文献/References:

[1]魏强,齐灿,罗飞,等.转移性去势抵抗性前列腺癌患者多西他赛化疗的预后分析[J].天津医科大学学报,2013,19(05):390.
[2]杨帮东,姜行康,齐 灿,等.尿液中PCA3评分对前列腺癌早期诊断的临床意义[J].天津医科大学学报,2013,19(06):487.
　YANG Bang-dong,JIANG Xing-kang,QI Can,et al.Clinical significance of urinary PCA3 score to diagnose prostate cancer[J].Journal of Tianjin Medical University,2013,19(01):487.
[3]王 超,余泉峰,徐 勇,等.经直肠超声造影诊断前列腺癌的临床分析[J].天津医科大学学报,2014,20(05):375.
　WANG Chao,YU Quan-feng,XU Yong,et al.Clinical analysis of contrast-enhanced transrectal ultrasonography for the diagnosis of prostate cancer[J].Journal of Tianjin Medical University,2014,20(01):375.
[4]张晓会,张志宏,徐 勇,等.合并症对局限性或局部晚期前列腺癌患者早期生存的影响[J].天津医科大学学报,2014,20(05):379.
　ZHANG Xiao-hui,ZHANG Zhi-hong,XU Yong,et al. Influence of complications on early survival of patients with localized or locally advanced prostate cancer[J].Journal of Tianjin Medical University,2014,20(01):379.
[5]盛 镔,张 蒙,马鹏德,等.核糖体蛋白L37在前列腺癌中的表达及临床意义[J].天津医科大学学报,2015,21(05):401.
　SHENG Bin,ZHANG Meng,MA Peng-de,et al.Expression of ribosomal protein L37 in prostate cancer and its clinical significance[J].Journal of Tianjin Medical University,2015,21(01):401.
[6]管明秀,周云丽,王 萌,等.TuM2-PK，tPSA，fPSA/tPSA和PSAD对PSA灰区前列腺癌诊断价值的比较[J].天津医科大学学报,2016,22(02):140.
　GUAN Ming-xiu,ZHOU Yun-li,WANG-Meng,et al.Diagnostic implication of TuM2-PK, tPSA, fPSA/tPSA ratio and PSAD for prostate cancer in PSA gray area[J].Journal of Tianjin Medical University,2016,22(01):140.
[7]李 江,张恩龙,赵 阳,等.前列腺癌靶向磁共振成像和光热治疗的实验研究[J].天津医科大学学报,2017,23(02):93.
　LI Jiang,ZHANG En-long,ZHAO Yang,et al.?Experimental research of targeted magnetic resonance imaging and photo thermal therapy for prostate cancer [J].Journal of Tianjin Medical University,2017,23(01):93.
[8]张一然,潘盼,连振鹏,等.磁共振扫描对经直肠超声引导前列腺穿刺活检的影响[J].天津医科大学学报,2017,23(02):99.
　ZHANG Yi-ran,PAN Pan,LIAN Zhen-peng,et al.Effect of magnetic resonance imaging scan on the?transrectal ultrasound?prostate biopsy[J].Journal of Tianjin Medical University,2017,23(01):99.
[9]薄志强,孙桂江,王 丽,等.CtBP2异常表达对前列腺癌PC3细胞增殖效应影响的研究[J].天津医科大学学报,2017,23(02):103.
　BO Zhi-qiang,SUNGui-jiang,WANG Li,et al.Effect of abnormal expression of CtBP2 on the proliferation of prostate cancer cell line PC3[J].Journal of Tianjin Medical University,2017,23(01):103.
[10]徐庆祝,牛远杰.Gleason 10分前列腺癌患者临床特点分析[J].天津医科大学学报,2017,23(04):361.
　XU Qing-zhu,NIU Yuan-jie.Clinical and pathological research of prostate cancer with Gleason score 10[J].Journal of Tianjin Medical University,2017,23(01):361.

备注/Memo

备注/Memo:
基金项目 天津市自然科学基金资助项目（11JCYBJC13900）作者简介 刘利维 （1975-），男，副主任医师，博士，研究方向：泌尿系统肿瘤；E-mail：liulw@tijmu.edu.cn。
更新日期/Last Update: 2014-03-29